Indication

Hereditary orotic aciduria, type I

Hereditary orotic aciduria, type I is an extremely rare autosomal recessive inborn error of pyrimidine metabolism caused by pathogenic variants in the UMPS gene. Read more about Hereditary orotic aciduria, type I

2 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Hereditary orotic aciduria, type I therapies.

Showing 1–2 of 2 drugs

Filter & compare in the drug finder →Opens the drug finder with Hereditary orotic aciduria, type I preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Hereditary orotic aciduria, type I.

Hereditary orotic aciduria, type I is an extremely rare autosomal recessive inborn error of pyrimidine metabolism caused by pathogenic variants in the UMPS gene.

This genetic defect results in a combined deficiency of both functional enzymatic domains of uridine monophosphate synthase: orotate phosphoribosyltransferase and orotidine-5'-monophosphate decarboxylase.

Pathophysiologically, the inability to synthesize uridine monophosphate impairs normal DNA and RNA synthesis and triggers massive urinary excretion of orotic acid.

Typically presenting in infancy, defining clinical manifestations include severe refractory megaloblastic anemia unresponsive to vitamin B12 and folate, failure to thrive, developmental delays, and orotic acid crystalluria, which may lead to urinary tract obstruction.

Personalize your experience

Follow Hereditary orotic aciduria, type I and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it